Consensus IMAX Corporation

Stocks

IMAX

CA45245E1097

Entertainment Production

Market Closed - NYSE 04:00:02 2026-09-04 pm EDT			5-day change	1st Jan Change
51.64 ^USD	-0.54%		+2.50%	+39.72%

Aug. 24	B. Riley Adjusts IMAX Price Target to $61 From $52, Maintains Buy Rating	MT
Aug. 17	IMAX Posts $47 Million Global Weekend Boosted by 'The Odyssey'	MT

Evolution of the Average Target: IMAX Corporation

Evolution of the Target Price: IMAX Corporation

Changes in Analyst Recommendations: IMAX Corporation

2f193b6a4.KHzAIoUjEOIHVe9UvRxorwe6mUTU8etUOdLrXmOt7Bc.GE6SEMpkfLZCMYsxz2sGmUXgqSa5pZIDV-euEwX_iGEbPqllyUJeqXJnmA~4b94c900f7aee394a873c7d5e448d0ee

Analysts' recommendations: IMAX Corporation

Aug. 24	B. Riley Adjusts IMAX Price Target to $61 From $52, Maintains Buy Rating	MT
Jul. 24	IMAX Q2 Results Reinforce Long-Term Growth Outlook, Wedbush Says	MT
Jul. 24	Barrington Research Adjusts IMAX Price Target to $50 From $46, Maintains Outperform Rating	MT
Jul. 24	B. Riley Adjusts Price Target on IMAX to $52 From $48, Maintains Buy Rating	MT
Jul. 24	Wedbush Adjusts Price Target on IMAX to $54 From $46, Maintains Outperform Rating	MT
Jul. 16	IMAX's H2 Outlook Remains Strong Despite Modest Q2 Growth, Wedbush Says	MT
Jul. 16	Wells Fargo Downgrades IMAX to Equalweight From Overweight, Cuts Price Target to $41 From $47	MT
Jul. 10	B. Riley Adjusts IMAX Price Target to $48 From $46, Maintains Buy Rating	MT
May. 18	IMAX on Track to Reach $1.4 Billion in Box Office Proceeds Despite Headwinds, B. Riley Says	MT
May. 04	Barrington Raises Price Target on IMAX to $46 From $42, Keeps Outperform Rating	MT
May. 01	IMAX is Poised to Surpass 50% EBITDA Margins by 2028 on Rise in Filmed-for-IMAX Titles, Wedbush Says	MT
Apr. 23	IMAX's Global Film Slate Likely to Support 'Robust' 2026, Wedbush Says	MT
Apr. 17	B. Riley Upgrades 2026 Box Office Outlook Following First-Quarter Beat	MT
Feb. 27	Macquarie Raises Price Target on IMAX to $45 From $44, Keeps Outperform Rating	MT
Feb. 26	IMAX Poised to Benefit from Multiple Factors, Wedbush Says	MT
Feb. 26	B. Riley Adjusts Price Target on IMAX to $46 From $44, Maintains Buy Rating	MT
Dec. 15	JPMorgan Upgrades IMAX to Overweight From Neutral, Adjusts Price Target to $47 From $32	MT
Dec. 08	IMAX EBITDA Margins Seen Surpassing 50% by 2028, Wedbush Says	MT
Dec. 08	Wedbush Raises Price Target on IMAX to $46 From $39, Keeps Outperform Rating	MT
Dec. 08	Barrington Raises Price Target on IMAX to $42 From $37, Keeps Outperform Rating	MT
Dec. 08	B. Riley Raises Price Target on IMAX to $44 From $40, Keeps Buy Rating	MT
Nov. 25	Goldman Sachs Upgrades IMAX to Neutral From Sell, Adjusts Price Target to $34 From $22	MT
25-10-24	IMAX Reports 'Superb' Q3 Results, Wedbush Says	MT
25-10-20	US Box Office Set to Rebound in Fourth Quarter, B. Riley Says	MT
25-09-22	Imax Likely to Surpass 'Peak' EBITDA Margins in Two Years, Wedbush Says	MT

More recommendations

Other Entertainment Production

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Objective/dr gap
IMAX CORPORATION		+7.77%
WARNER MUSIC GROUP CORP.		+28.15%
TKO GROUP HOLDINGS, INC.		+24.27%
BOLLORÉ SE		+13.43%
SEGA SAMMY HOLDINGS INC.		-2.06%
TOEI ANIMATION CO.,LTD.		+3.53%
TOEI COMPANY, LTD.	-	-1.67%
HAVAS N.V.		+16.6%
Average		+11.25%
Weighted average by Cap.		+17.30%